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Federica Pisati2, Mirjam A. Moser3, Rosella Visintin1, Christian Seiser3 & Susanna Chiocca1
Histone deacetylases (HDACs) catalyze the removal of acetyl molecules from histone and non-
histone substrates playing important roles in chromatin remodeling and control of gene expression. 
Class I HDAC1 is a critical regulator of cell cycle progression, cellular proliferation and differentiation 
during development; it is also regulated by many post-translational modifications (PTMs). Herein we 
characterize a new mitosis-specific phosphorylation of HDAC1 driven by Aurora kinases A and B. We 
show that this phosphorylation affects HDAC1 enzymatic activity and it is critical for the maintenance 
of a proper proliferative and developmental plan in a complex organism. Notably, we find that Aurora-
dependent phosphorylation of HDAC1 regulates histone acetylation by modulating the expression 
of genes directly involved in the developing zebrafish central nervous system. Our data represent a 
step towards the comprehension of HDAC1 regulation by its PTM code, with important implications in 
unravelling its roles both in physiology and pathology.
Histone deacetylases (HDACs) are enzymes which remove acetyl moieties from ε -NH3 groups of lysines from 
both nucleosomal histones and non-histone proteins1; they are also known as “lysine deacetylases” (K[Lys]DAC)2. 
In humans, 18 HDACs have been identified and are divided into four classes. Class I, II and IV all include 
Zn2+-dependent enzymes3. Class III includes NAD+-dependent HDACs called Sirtuins (Sirt1-7)4. Class I 
HDACs, which include HDAC1, 2, 3 and 8 are ubiquitously expressed in all tissues5 and have predominantly 
nuclear localization. The highly related HDAC1 and HDAC2 proteins are crucial for development and physiol-
ogy of the heart6. They are also central regulators of cell cycle progression, apoptosis and cellular proliferation. 
Recent evidence has shown how the fine regulation of HDAC1 and HDAC2 protein levels and the maintenance of 
a proper balance between the two enzymes are critical in tumour onset and progression7–9,10. Thus, together with 
HDAC2, HDAC1 is believed to be one of the master regulators of chromatin acetylation and gene expression.
HDAC1 knockout mice die at embryonic day 9.5 (E9.5)11. Different human cancer cell lines depleted of HDAC1 
have an aberrant cell cycle, accompanied by loss of mitotic cells and an increase in apoptosis12. HDAC1 and 
HDAC2 regulate G1/S transition by binding to p21WAF/CIP1 and p57Kip2 promoters13,14, whereas inhibition of HDAC 
enzymatic activities by trichostatin A (TSA)15 or depletion of HDAC1/HDAC2 affects the G2/M progression12. 
HDAC1 and HDAC2 often display redundant roles and compensatory effects. For example, differentiation of 
neurons from neuronal precursors requires either HDAC1 or HDAC216, while concomitant deletion of both 
deacetylases causes mitotic catastrophe with consequent cell death17. Consistently, depletion of either HDAC1 or 
HDAC2 in cancer cells induces a compensatory upregulation of HDAC2 or HDAC1 respectively17.
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In zebrafish, Hdac1 is specifically required to promote neuronal specification in the developing Central 
Nervous System (CNS)18–21. Hdac1 is also needed for the switch from proliferation to differentiation in the zebraf-
ish retina and optic stalk. It promotes cell cycle exit by antagonizing Notch and Wnt signaling pathways, correlat-
ing with cyclins D1 and E2 repression and leading to CDK inhibitor expression and neural progenitors cell cycle 
exit20,21. More in general, in zebrafish Hdac1 can function either as a positive or as a negative regulator of the cell 
cycle, depending on the tissue and the cell type in which it is active.
HDAC1 is a target of a complex code of post-translational modifications (PTMs, fully reviewed in ref. 22). 
Most recently, we have uncovered a SUMO-dependent mechanism that regulates its protein stability and expres-
sion in cancer cells23 and a novel phosphorylation of HDAC1 mediated by mitogens, describing a cross-talk 
between HDAC1 and PI3K pathways with clinical implications towards the treatment of cancer24. In this study 
we characterize an Aurora kinases-dependent, mitosis specific phosphorylation occurring on HDAC1, whose 
biological significance is further underscored by the fact that some viruses induce hyperphosphorylation of this 
HDAC at the same residues during the early phases of infection25–27. Furthermore, we provide evidence that this 
phosphorylation modulates the activity of HDAC1 and plays a role in regulating the proper cell cycle progression 
and developmental plan of zebrafish embryos. Our results contribute to elucidate how HDAC1 function may be 
finely regulated by a PTM, shedding light on the rationale of single HDACs regulation.
Results
Aurora kinases phosphorylate HDAC1 in mitosis and regulate its enzymatic activity. It has been 
long known that HDAC1 is a critical player for the correct progression of cell cycle, but knowledge on how it is 
regulated remains poor. To gain insights into the molecular mechanisms, we analyzed by SDS-PAGE HDAC1 
protein levels and mobility during cell cycle (Fig. 1a). HeLa cells were synchronized in different phases of the 
cell cycle as described in Supplementary Methods. Uniquely in mitotic cells, we observed the appearance of a 
slow-migrating band for HDAC1, but not for the less related class I HDAC3. Next, to better analyze the appear-
ance of this modified form of HDAC1 as cells proceeded towards mitosis, HeLa cells were synchronized at the 
G1/S boundary by a double thymidine block, released in fresh medium containing nocodazole and samples were 
collected every hour (Supplementary Fig. S1a). The modified form of HDAC1 appeared after 7 hours, when cells 
started to enter mitosis and the maximum level of modification peaked at 9 hours corresponding to the maximal 
level of phospho-serine10-H3 (H3S10ph), a known marker of mitosis28. To evaluate the disappearance of the 
modified form of HDAC1, a purified mitotic population was released from nocodazole block, in fresh medium, 
to allow it to re-enter in a new G1 and samples were collected at the indicated times (Supplementary Fig. S1a). 
The same time-course was also performed on U2OS cells, with similar results (data not shown). The slow-mi-
grating band of HDAC1 was likely due to a post-translational modification. It is well established that in mitosis 
there is a massive wave of phosphorylation for thousands of protein substrates29. Moreover, a previous study 
showed that the treatment of cells with the phosphatase inhibitor okadaic acid, which induces mitotic arrest, 
caused the appearance of a hyper-phosphorylated form of HDAC130. We thus performed in vitro phosphatase 
assays using lambda phosphatase on extracts isolated from asynchronous and mitotic HeLa cells. As shown in 
Supplementary Fig. S1b, mitotic slow-migrating bands were lost after treatment with phosphatase, indicating 
that the slower migration of HDAC1 was indeed caused by phosphorylation. Similar results were obtained by 
treating mitotic samples with Antarctic phosphatase31 or Calf Intestinal Phosphatase32. Mitotic phosphorylation 
of HDAC1 was detected also in other cell types: 293T fibroblasts, U2OS and Saos-2 osteosarcoma cells, normal 
and tumoral primary human breast cells, independently from their p53 expression (data not shown) indicating 
that mitotic phosphorylation of HDAC1 is a general hallmark of mitosis. We thus focused on kinases activated 
specifically in this phase to identify the one(s) involved in this phosphorylation. Among the mitotic-restricted 
kinases, putative predicted consensus sites for Plk1 (Polo-like kinase 1) (serine 236 for HDAC1) and Aurora A/B 
kinases (serine 406 for HDAC1) were identified (Supplementary Fig. S1c). We then synchronized HeLa cells in 
G1/S by a thymidine block and cells were released in fresh medium for 4 hours, synchronized in mitosis by noco-
dazole with or without the Aurora kinase inhibitors Hesperadin or ZM-447439 or the Plk1 inhibitor BI-2536; in 
the last hour of treatment, we added proteasome inhibitor MG132. Mitotic cells were collected after 5.5 hours and 
cell lysates were analyzed. As shown (Supplementary Fig. S1d), the phosphorylated forms of HDAC1 disappeared 
after inhibition of Aurora kinase activity. In contrast, inhibition of Plk1 had no effect on the mitotic phosphoryla-
tion of HDAC1 but impaired the phosphorylation of its known substrate Cdc25c. Our data indicated that Aurora 
kinases are likely the kinases responsible for HDAC1 mitotic phosphorylation, while Plk1 had no detectable role. 
Moreover, partial colocalization of HDAC1 and Aurora A in mitosis had been previously reported33. To formally 
address this point, we performed RNA interference to specifically knock down Aurora A and B, alone or in com-
bination, and looked at the effect on the mitotic phosphorylated fractions of HDAC1. HeLa cells were subjected 
to two cycles of RNA interference using siRNA, while concomitantly synchronizing them at the G1/S boundary 
by double thymidine block, as schematized in Fig. 1b. After the second block, cells were released in nocodazole 
containing medium to enrich for the mitotic population: mitotic phosphorylation of HDAC1 was reduced when 
single Aurora A or B were knocked down, with an even greater reduction when both kinases were simultaneously 
depleted (Fig. 1b and Supplementary Fig. S1e). These data confirmed the specific involvement of Aurora kinases 
in mitotic phosphorylation; moreover, they also showed that in vivo HDAC1 phosphorylation can be driven by 
both Aurora A and B kinases.
To assess whether Aurora A and B could directly modify HDAC1, we performed an in vitro kinase assay using 
recombinant Aurora A/TPX2 or Aurora B/INCENP as enzymes and HDAC1, HDAC3 or histone 3 as substrates 
in the presence of [32P]-γ -ATP. The proteins were then separated by SDS-PAGE and the gel was exposed for auto-
radiography (Supplementary Fig. S1f). We observed that HDAC1 is phosphorylated by both Aurora A and Aurora 
B, in accordance with the in vivo data (Fig. 1b and Supplementary Fig. S1d,e). HDAC3, as expected, was neither 
modified by Aurora A nor B (Supplementary Fig. S1a,d,f). By mutagenesis assays (Supplementary Fig. S1g), 
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we then corroborated that HDAC1 is phosphorylated in vitro on serine 406 by both Aurora A and Aurora B. 
Phosphorylation of serine 406-HDAC1 (S406A) by Aurora B in vitro was also confirmed by mass spectrom-
etry after in vitro kinase assay31. To further validate the identified phosphorylation sites, Flag-tagged HDAC1 
wild type and HDAC1 S406A mutant were expressed in HeLa cells and analyzed during mitosis (Fig. 1c). As 
expected, HDAC1 wild type showed the corresponding slow-migrating phosphorylated forms, which were lost 
in the mutant. Furthermore, using the BT-15 antibody31 that specifically recognizes serine 406 phosphorylation 
Figure 1. HDAC1 Aurora-dependent phosphorylation occurs specifically in mitosis and regulates its 
enzymatic activity. (a) HeLa cells were synchronized in different phases as described in Supplementary 
Methods and protein lysates were analyzed by western blot with the indicated antibodies. Vinculin is used 
as loading control. Phosphorylation levels of serine 10 of histone 3 (H3S10ph) was used as a mitotic marker 
and evaluated by FACS. Percentages of H3S10ph-positive cells are reported. (b) HeLa cells were subjected to 
two cycles of RNA interference with the indicated siRNA, synchronized at G1/S boundary and released with 
nocodazole as schematized in the cartoon. Cells were collected at 9.5 hours by mitotic shaking and analyzed 
by western blot with the indicated antibodies. Cdc25c phosphorylation is used as mitotic marker and Vinculin 
as loading control. (c) HeLa cells were transfected with pBJ5-HDAC1-Flag or pBJ5-HDAC1 S406A-Flag. Cells 
were synchronized in mitosis and analyzed by western blot with the indicated antibodies. H3S10ph is used as 
mitotic marker and Vinculin as loading control. (d) HeLa cells were transfected with 10 μ g of pBJ5-HDAC-Flag 
various constructs as depicted and synchronized in mitosis. Lysates were used for immunoprecipitation (IP) 
with the Flag antibody. Three quarters of the IP were incubated with 10 μ l of 3CH3-acetylated histones at 30 °C 
for 1 hour and radioactivity released was measured at the scintillation counter at count per minute (cpm); the 
remaining part was analyzed by Western blot. H3S10ph is used as mitotic marker, Vinculin as loading control. 
HDAC1 S421-423A (2S) mutant was used as the catalytically dead control40. The average of three independent 
experiments was reported as fold change versus HDAC1 wt, standard error (SEM) was indicated by the error 
bars; the significance was calculated by one sample t test algorithm. * P value < 0.05; * * P value < 0.001; ns: not 
significant. In all western blots the asterisks denote the phosphorylated form of the protein.
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on HDAC1 we clearly detected this modified form of HDAC1 only in untreated mitotic samples (Supplementary 
Fig. S1b). Finally, enzymatic activity assays carried out in mitotic cells showed reduced enzymatic activity of the 
phospho-mimetic form of HDAC1 S406E compared to wild type (Fig. 1d). Altogether, these data suggest that 
HDAC1 is phosphorylated specifically in mitosis by Aurora kinases A and B and this modification modulates the 
deacetylase activity of the enzyme.
HDAC1 Aurora-dependent phosphorylation is critical for a proper developmental plan and con-
trols the accurate cell cycle progression of zebrafish embryos. In many cellular systems, due to the 
well-known compensation mechanism between HDAC1 and HDAC2, depletion of HDAC1 leads to an increased 
level of HDAC2 protein and vice versa11–13. Unlike mammals, zebrafish do not possess two distinct HDAC1 
and HDAC2 genes, but they only have one, which is more similar to human HDAC1 in terms of amino acidic 
sequence. Perfectly coordinated and regulated cell cycles are the conditio sine qua non for the proper completion of 
a developmental program and also very slight differences likely may have dramatic impact. Moreover, many stud-
ies have pointed out the crucial role of Hdac1 during zebrafish development, in particular of the nervous system, 
the retina and the optical stalk20. Thus, to investigate the possible biological role of mitotic HDAC1 phosphoryla-
tion we used zebrafish embryos as a model. Our experimental approach consisted in knocking down the endoge-
nous hdac1 in zebrafish embryos right after fertilization using the morpholino strategy and reinserting the human 
HDAC1 wild type or Aurora phospho mutants S406A or S406E mRNA (Fig. 2a, the left panel of Supplementary 
Fig. S2a). We observed that the injection of a scramble morpholino did not affect the morphology of 72 hpf 
(hours post fertilization) embryos. On the contrary, as already known34, hdac1 MO injected embryos displayed 
multiple developmental and morphological defects due to the absence of Hdac1: reduced size of head (hd) and 
jaw (j), curled down tail (ct); moreover, a pericardial edema (pe) was clearly visible. Also pectoral fins (pf) were 
missing, otoliths (* ) were smaller and close together and melanocyte migration was defective. The expression of 
the human HDAC1 wt by co-injection of its mRNA together with hdac1 MO significantly rescued the morphants 
phenotype: 90% of the embryos (out of 120) displayed a wild type-like phenotype with relatively normal heads, 
eyes and jaw structures and a straight antero-posterior body axis; reabsorption of the pericardial oedema, proper 
melanocyte distribution and an outline of pectoral fins are visible. Interestingly, the human Aurora phospho-null 
S406A mutant only partially rescued essential features of the morphant phenotype. In fact, although reduced head 
size, absence of pectoral fins and cell migration defects observed in morphant embryos still persisted, a proper 
body axis and pericardial oedema were recovered. Notably, all the body structures showed a striking develop-
mental delay, as indicated by the late migration of the head melanocytes and yolk reabsorption. About 56% of 
hHDAC1 S406A injected embryos (out of 80) showed a wild type-like phenotype. Conversely, the expression 
of the human phospho-mimetic HDAC1 S406E was not able to rescue the phenotype in an hdac1 morpholino 
background: strong defects in the development of the head and the eye were present, pericardial oedema was not 
reabsorbed and jaw and pectoral fins failed to form. Furthermore, there was no recovery in the body axis: a curled 
down tail was present and a random distribution of melanocytes was visible, particularly in the head. About 70% 
of the hHDAC1 S406E injected embryos (out of 70) had an hdac1 MO-like phenotype. We verified the expres-
sion of the injected human proteins in an hdac1 MO background (the right panel of Supplementary Fig. S2a) 
and using the BT-15 antibody31, we assessed whether also the zebrafish orthologs of the human Aurora kinases 
(Supplementary Fig. S2b) were able to phosphorylate hHDAC1 in zebrafish embryos. Zebrafish embryos were 
injected with hdac1 morpholino alone or in combination with hHDAC1 Aurora phospho mutants, collected at 
24 hpf and immunostained with BT-15 antibody. As expected, in embryos injected with a scramble morpholino 
no BT-15 positive cells were detected (Supplementary Fig. S3a). This was due to the high specificity of the anti-
body for the human form of HDAC1 (human and zebrafish HDAC1 protein differ by a 4 amino acids mismatch 
in the BT-15 epitope (Supplementary Fig. S2b)). Embryos co-injected with hdac1 morpholino and hHDAC1 wt 
displayed a limited number of BT-15 positive cells: indeed, among all the mitotic (H3S10ph positive) cells, only 
prophase cells were recognized by the HDAC1 pS406 antibody (Supplementary Fig. S3a,b), as expected from our 
mammalian data which show HDAC1 Aurora-dependent phosphorylation in prophase31. Moreover, the injec-
tion of the phospho null mutant hHDAC1 S406A in a hdac1 morpholino background completely abolished the 
BT-15 staining; on the contrary, the hHDAC1 S406E mutant mimicked the Aurora driven phosphorylation of 
the protein31, and therefore all the cells of the embryos injected with hdac1 MO plus hHDAC1 S406E were BT-15 
positive, independently of the phases of the cell cycle.
Given the well-established role of HDAC1 in controlling cell cycle and proliferation, we then monitored cell 
cycle progression at 72 hpf in embryos expressing hdac1 MO alone or in combination with human HDAC1 
Aurora-phospho mutants and in control by Propidium Iodide (PI) staining and fluorescence-activated cell sorting 
(FACS) analyses. Comparing cell populations of embryos heads between scramble and hdac1 morphant embryos, 
we found a high and significant reduction in the G2-M populations and a corresponding increase in interphase 
cells (Fig. 2b). There was nearly the same change in cell cycle distribution upon co-injection of the hdac1 MO and 
hHDAC1 S406E, suggesting that the phospho-mimetic hHDAC1 mutant failed to revert the cell cycle progres-
sion phenotype of hdac1 morphant embryos. On the contrary, comparing cells from heads of control embryos 
and embryos co-injected with hdac1 MO and hHDAC1wt or hHDAC1 S406A mutant, we could not detect any 
differences in cell cycle progression at 72 hpf. Taken together these results indicated that a proper balance of the 
Aurora-driven phosphorylation of HDAC1 is critical for the maintenance of a proper proliferative and develop-
mental plan in a complex organism.
HDAC1 Aurora-dependent phosphorylation regulates histone acetylation in hdac1 morphant 
embryos and controls expression of CNS regulatory genes during zebrafish development. To 
test whether the Aurora-dependent phosphorylation of HDAC1 is important in controlling the deacetylase 
activity of the enzyme in vivo, we performed immunohistochemistry experiments. Sections of hdac1 morphant 
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Figure 2. Aurora-driven phosphorylation of HDAC1 is crucial for zebrafish developmental plan and 
modulates proliferation in hdac1 morphant zebrafish embryos. (a,b) Embryos were injected, at one cell stage, 
with Scramble MO or hdac1 MO alone or in combination with hHDAC1 aurora phospho mutants and collected 
at 72 hours post fertilization (hpf). (a) Lateral and dorsal overviews of zebrafish embryos at 72 hpf. Arrows 
highlight morphological differences between embryos. hd: head, m: head melanocytes, j: jaw, e: eye,  
pe: pericardial edema, y: yolk, pf: pectoral ns, t: tail, ct: curled down tail, * : otoliths. (b) Flow cytometry analysis 
by PI staining of cell suspensions prepared from 72 hpf heads of control embryos and embryos injected at one-
cell stage with hdac1 MO alone or in combination with hHDAC1 wt, hHDAC1 S406A or hHDAC1 S406E. 
The percentage of G2-M cells population compared with the control is reported for every sample. The average 
of three independent experiments was reported, standard error (SEM) was indicated by the error bars; the 
significance was calculated by one sample t-test algorithm. * P value < 0.05.
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embryos or embryos injected with hdac1 MO + hHDAC1 wt, S406A or S406E mutants were immunostained with 
(K8, K12) acetyl-Histone H4 antibody9,35 and the acetylation levels were compared to those of control embryos 
at 72 hpf, where there was complete abrogation of maternal hdac1 (the left panel of Supplementary Fig. S2a). To 
make the data quantitatively and qualitatively comparable, for the counting of positive cells we decided to con-
sider the same brain region of 72 hpf embryos for all samples, in particular the developing diencephalon, which is 
located between the eyes (Fig. 3a, denoted as “d”, and Supplementary Fig. S4). Observing the brain morphology in 
the sections of morphant embryos, a dramatic effect of Hdac1 KD on brain architecture is clearly visible, mainly 
due to an abnormal enlargement of the brain ventricles (bv) that compresses the surrounding tissues. Moreover, 
the analysis of embryos sections confirmed that hHDAC1 wt mRNA rescued almost completely the morphology 
of the brain caused by the KD of endogenous Hdac1, while the injection of the two hHDAC1 Aurora mutants 
mRNAs only weakly rescued Hdac1 KD (hHDAC1 S406A) or did not rescue at all the morphant phenotype 
(hHDAC1 S406E). As expected, knock down of endogenous Hdac1 in morphant embryos increased the per-
centage of strong positive histone H4 acetylated (acH4) cells compared to uninjected embryos20,36. Interestingly, 
we observed a significant increase in the acetylation level in the diencephalon of embryos injected with hdac1 
MO + hHDAC1 S406E in comparison to both controls (uninjected and hdac1 MO + hHDAC1 wt), suggesting 
that also in an in vivo model the Aurora phospho-mimetic form of hHDAC1 failed to deacetylate its substrates. 
Conversely, embryos co-injected with hdac1 MO + hHDAC1 wt or hdac1 MO + hHDAC1 S406A, were able to 
restore the acetylation level in 72 hpf embryos brain. Control experiments were also performed to check the 
expression of human HDAC1 wt and mutants in injected embryos; as shown in the right panel of Supplementary 
Fig. S2a all three constructs were properly expressed. Notably, hHDAC1 wt expression was stronger compared to 
the two mutants; this might also explain the lower level of histone H4 acetylation in hHDAC1 wt samples com-
pared to uninjected.
We then asked whether HDAC1 Aurora mutants exert their regulation by an epigenetic mechanism. To ver-
ify this hypothesis, we performed on heads of 72 hpf embryos injected at one-cell stage, with hdac1 MO alone 
or in combination with hHDAC1 wt, S406A or S406E, a chromatin immunoprecipitation (ChIP) experiment 
with anti-acetylated lysine H3K27 antibody. The ChIP experiment was coupled to quantitative real-time PCR 
(RTqPCR) to evaluate the enrichment in the acetylation of the promoter of selected genes compared to their input 
(Supplementary Table S2). The genes used for the quantitative analysis were chosen from a list of genes involved 
in zebrafish developing CNS and retina, whose expression significantly changed upon hdac1 ablation36. Figure 3b 
displays the trend of acetylated promoters of ten genes under hdac1 knock down and/or complementation with 
the hHDAC1 Aurora phospho mutants. Ablation of the endogenous Hdac1 led to an increased H3K27 acetylation 
level of each promoter of the genes compared to the IgG control; notably, acetylated H3K27 highly increased also 
upon co-injection of hdac1 MO together with hHDAC1 phospho-mimetic, supporting our previous findings 
of a reduced deacetylating activity for hHDAC1 S406E mutant. On the contrary, expression of hHDAC1 wt in 
morphant embryos completely restored the acetylation level in the promoter of the genes. To further validate our 
hypothesis, we checked the expression level of the genes selected for the ChIP analysis. To this aim, RNA was 
extracted from the heads of 72 hpf embryos injected right after fertilization with Scramble MO or hdac1 MO 
alone or in combination with hHDAC1 Aurora phospho-mutants and RTqPCR were performed to measure the 
expression level of our subset of genes (Supplementary Table S3).
As shown in Fig. 3c, the vast majority of the genes exhibit comparable expression levels upon ablation of the 
endogenous hdac1 or injection of hdac1 MO plus hHDAC1 S406E mutant; whereas the presence of hHDAC1 
wt or S406A in a morpholino background almost completely restored the expression levels of the genes. Taken 
together, our data indicate that HDAC1 Aurora-dependent phosphorylation is involved in the control of the cat-
alytic activity of the enzyme both regulating histone acetylation levels and modulating expression of neurogenic 
regulatory genes throughout the zebrafish developing CNS.
Discussion/Concluding Remarks
Proliferation and differentiation are two interconnected pathways, especially during development, where every 
event of cell division must be strictly regulated in space and time to successfully complete the developmental 
plan. Our hypothesis is the following (Fig. 4): as cells progress from G2 to metaphase, they need to condense their 
chromatin, monitor the process and correct any abnormalities in chromatin architecture. HDAC1 has an impor-
tant role in this process since deacetylation of key residues, such as H3K9, is a prerequisite for mitotic DNA con-
densation, but at a certain point HDAC1 activity must be stopped and the enzyme displaced from chromatin32. 
Our data suggest that Aurora kinases phosphorylate HDAC1 in prophase, right after cells enter mitosis. This 
phosphorylation, by impacting on the deacetylase activity of the enzyme, has an effect on different levels: 1) on 
expression level, modulating histones’ acetylation and gene expression of CNS-related genes and 2) on prolifer-
ation level, controlling proper cell cycle progression. Therefore, the Aurora-driven phosphorylation of HDAC1 
could represent a further mechanism by which cells control the balance between proliferation and differentiation 
to ensure the inheritance of important gene signatures in the next generation of cells.
Specifically, in physiological conditions, S406 HDAC1 phosphorylation, even though very dynamically, results 
in transiently increased promoter acetylation of genes expressed in the CNS or with CNS-oriented functions, thus 
modulating their expression and enabling an accurate embryos’ development.
Thereafter, the prompt removal of the phosphate group brings promoters’ acetylation and genes’ expression 
levels back to their basal state. In a more exacerbated condition, i.e. mimicking HDAC1 phosphorylation by 
replacing the wildtype protein with HDAC1 S406E, the enzyme is constitutively less active; thereby the promot-
ers of above mentioned genes stay highly acetylated. This situation lasting for quite a long time causes an over-
all morphological impairment and most importantly does not allow cells to properly go through the cell cycle. 
Moreover, we reasoned that it is likely that cells, which miss S406-dephosphorylated HDAC1 display a prolonged 
interphase due to the increased expression of factors such a Gadd45aa. It has been shown that overexpression of 
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Figure 3. Aurora dependent phosphorylation of HDAC1 modulates histone acetylation and the expression of 
a core of CNS-related genes in zebrafish embryos. (a–c) Embryos were injected, at one cell stage, with Scramble 
MO (b,c) or hdac1 MO alone or in combination with hHDAC1 aurora phospho mutants and collected at 72 hpf. 
(a) Immunohistochemistry staining with haematoxylin and eosin (H&E uninjected panel: d: diencephalon;  
pe: pigmented epithelium; tr: trabecular; rc: rods and cones; gcl: ganglion cell layer; i: iris; m: melanocytes;  
bv: brain ventricle) and with haematoxylin (blue) and anti-acetylated histone antibody (brown). Quantification 
was performed and expressed as percentage of strong positive histone H4 acetylated pixels ± SEM in the 
diencephalon area. All samples were compared to uninjected sample and in particular hdac1 MO + hHDAC1 
S406E was also compared to hdac1 MO + hHDAC1 wt. * * P value < 0.01; * * * P value < 0.001; ns: not significant. 
Scale bar corresponds to 100 μ m. (b) Chromatin immunoprecipitation (ChIP) analysis of H3K27 acetylated cis-
regulatory regions of Hdac1-regulated genes. Representative data from at least two independent experiments are 
shown; RTqPCR data are presented as mean ± S.E.M. of three replicates. (c) Gene expression analysis of Hdac1-
regulated genes. Representative data from three independent experiments are shown; RTqPCR data are presented 
as mean ± S.E.M. of three replicates. TBP is used as housekeeping.
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the mammalian homolog Gadd45 prevents G1/S transition37,38. Alternatively or in addition, histone hyperacetyl-
ation in the absence of fully active S406-dephosphorylated HDAC1 might directly interfere with normal S-phase 
transition given the known role of HDAC1 in DNA replication39.
On the contrary, the absolute abrogation of the HDAC1 Aurora-dependent phosphorylation does not affect 
proper cell cycle progression, but embryos display a clear developmental delay probably due to the fact that 
expression of genes persists at basal levels. In conclusion, we hypothesize that while controlling the deacetylase 
activity of HDAC1, the Aurora-dependent phosphorylation on one hand modulates the expression of genes 
directly involved in zebrafish development, and, on the other hand, acts as sensor of the transcriptional process, 
regulating in a fine-tuned manner proper cell cycle progression.
Experimental Procedures
Zebrafish strains and maintenance. Zebrafish strains were maintained and bred according to standard 
procedures. Embryos from AB wild type strain were maintained in E3 water (5 mM NaCl, 0.17 mM KCl, 0.33 mM 
CaCl2, 0.33 mM MgSO4) at 28.5 °C.
Ethics statement. Fish were maintained/raised according to EU regulations on laboratory animals.
All experimental protocols (project number 02/14) were approved by the Institutional Animal Care and Use 
Committee (IACUC) of IFOM (FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan Italy) and 
by the Italian Ministry of Health.
mRNAs and morpholino injections in zebrafish embryos. mRNAs were synthesized from NotI 
digested pCS2+hHDAC1 wt, S406A, S406E plasmids using mMessage mMachine kit (Ambion) and purified with 
Microcon YM-100 (Millipore) filter devices. RNA quality was assayed by means of gel electrophoresis. mRNAs 
was then diluted in 1X Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM 
HEPES, pH 7.6) at final concentration of 120 ng/μ l and pressure injected into 1–2 cell stage embryos.
Morpholinos were purchased by Gene Tools, LLC. The morpholino against hdac1 (5′ -TTGTTCCTT 
GAGAACTCAGCGCCAT-3′ ) was targeted to the translational initiation site, as ref. 19. The scramble mor-
pholino sequences was: 5′ -CCTCTTACCTCAGTTACAATTTATA-3′ . Morpholinos (0,15 mM) were diluted and 
injected as described above.
Chromatin immunoprecipitation (ChIP) and quantitative real-time PCR (RTqPCR). Fixed head 
embryos cells were lysed in RIPA buffer and after chromatin shearing by sonication, incubated at 4 °C overnight 
with protein G Dynabeads (Invitrogen) and anti-acetylated H3K27 antibody (Abcam ab4729). Extended methods 
are in the Supplementary Information.
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